Sunday, September 14th, 2025

Centurion Accommodation REIT IPO 2025: 7.5–8.1% Yield, Low Gearing, Cornerstone-Backed

Centurion Accommodation REIT (CA-REIT) IPO: 27k Beds, 7.5–8.1% Yield, Low-20% Gearing

TL;DR: Income-focused REIT with high occupancies (~97%), attractive forecast yields (7.47% in FY2026; 8.11% in FY2027), conservative leverage (~20.9% at IPO), and strong cornerstone demand. Debut likely steady to mildly positive versus offer price.

Quick Facts

Offer Price
S$0.88
Offer Size
262,160,900 units
Forecast Yield
7.47% (FY26) / 8.11% (FY27)
Leverage
~20.9% at IPO

Units outstanding post-offer: ~1,719,331,000 • Over-allotment option: 51,137,000 units (19.5% of offer)

The Story in One Minute

Centurion Accommodation REIT holds a diversified accommodation portfolio spanning Singapore purpose-built worker accommodation (PBWA) and UK/Australia purpose-built student accommodation (PBSA). With ~26,870 beds across 14 assets and ~97% occupancy, the REIT lists with conservative gearing and a strong cornerstone line-up—positioning it as a yield play with room to grow.

1) Use of Funds & Dividend Policy

  • Growth-driven listing: Proceeds fund the acquisition of the Initial Portfolio, transaction costs, and working capital—this is not a debt-reduction exercise.
  • Distribution cadence: Quarterly (Mar/Jun/Sep/Dec) with forecast yields of 7.47% (FY2026) and 8.11% (FY2027) at the S$0.88 offer price.
  • Balance sheet headroom: ~20.9% leverage at IPO leaves ample capacity for future acquisitions.

2) Sizing & Day-1 Dynamics

Component Details
Offer Price S$0.88 per unit
Total Offer 262,160,900 units
Placement Tranche 248,960,900 units (~S$219.1m)
Public Offer 13,200,000 units (~S$11.6m)
Gross Proceeds (Offer) ~S$230.7m
Units Outstanding (Post-Offer) ~1,719,331,000
Free Float from Offer ~15.2% (up to ~18.2% if over-allotment fully used)
Day-1 Read Cornerstone weight + stabilisation suggest a steady to mildly positive debut rather than a large “pop”.

3) Cornerstones, Demand & Lock-ups

Cornerstone investors (selected): BlackRock, FIL Investment Management (Hong Kong) Ltd (approx. 153.41m units, ~8.9% post-IPO), Eastspring, Lion Global Investors, Principal GI (Singapore), UBS (Singapore Branch, own book), Value Partners, DWS Investments Australia, Ong Pang Aik, DBS Bank Ltd (own book).

  • Aggregate cornerstone size: ~614.0m units at offer price.
  • Lock-ups: Sponsor and related parties: 6 months + next 6 months (50%). Cornerstones generally without lock-up (DBS own-book portion locked 6 months).
  • Subscription multiples: Not announced at preliminary stage.

4) Deal Team & Support

Joint Issue Managers & Global Coordinators: DBS Bank Ltd; UBS AG, Singapore Branch

Joint Bookrunners & Underwriters: DBS; UBS (Singapore Branch); United Overseas Bank; UOB Kay Hian; Maybank Securities

Co-Managers: CGS International Securities; Hong Leong Finance

Stabilising Manager: UBS AG, Singapore Branch (over-allotment option 19.5% of offer)

Sponsor: Centurion Corporation Limited

Debut take: Full underwriting and a sizeable stabilisation facility typically support orderly price action on day one.

5) What the Business Looks Like

Business Model & Footprint

  • Assets: 14 properties (5 PBWA in Singapore; 8 PBSA in UK; 1 PBSA in Australia)
  • Beds: ~26,870 (PBWA ~21,282; PBSA ~2,772)
  • Occupancy: ~96.9% (PBWA) / ~96.8% (PBSA)
  • Appraised Value: ~S$1.84b

Financial Health (Pro Forma)

  • Revenue/NPI Growth: Initial portfolio CAGR FY2022–FY2024 of ~23.7% (revenue) and ~29.2% (NPI)
  • Leverage: ~20.9% at IPO; ~31.0% post Epiisod Macquarie Park acquisition
  • ICR: ~4.6x (FY2026) and ~4.8x (FY2027)
  • NAV/Unit: ~S$0.837 (implies ~1.05x P/B at S$0.88)

Market Position

PBWA anchored by long-standing construction and allied-sector tenants; PBSA located near target universities in UK cities (e.g., Manchester, Liverpool, Bristol, Nottingham) and in Sydney/Adelaide—supporting persistently high occupancy.

Management Team

Manager: Centurion Asset Management Pte. Ltd.

CEO: Tony Bin Hee Din • CFO: Teo Chee Kiat • CIO: Ang Cher Hoong (Ginny)

Board (Manager): Loh Kim Kang David (Chairman), Tan Kok Kwee (Lead INED), Choy Bing Choong (INED), Cheam Heng Haw (INED), Wong Kok Hoe (NINED)

6) Context: Trends, Timing & Risks

a) Sector & Demand

  • PBWA (SG): Structural demand from construction and allied sectors; robust bed take-up.
  • PBSA (UK/AU): Persistent bed shortages in key university cities sustain high occupancy and pricing power.

b) Timing

Forecast yields of ~7.5–8.1% at listing with low initial leverage provide both income and acquisition headroom—well-timed for investors prioritising yield and balance-sheet resilience.

c) Macro & Financing

  • REIT leverage cap at 50%; IPO gearing ~20.9% offers significant buffer.
  • No near-term debt cliffs disclosed; multi-currency facilities in place.

d) Newsflow

Preliminary prospectus lodged 11 Sep 2025; pricing, subscription stats, and allotment results will follow the bookbuild.

e) Overall Market Conditions

High occupancies, cornerstone weight, and stabilisation feature point to supportive debut conditions.

f) Key Risks

  • Policy and cycle exposure in Singapore construction-linked PBWA.
  • Revenue concentration: PBWA is the larger NPI driver; construction accounts for a significant share of PBWA rents.
  • FX/interest-rate sensitivity (SGD/GBP/AUD).
  • Cornerstone unlocks (most not locked) can add supply after listing.

g) Growth Strategy

Organic yield optimisation, asset enhancement, and acquisition pipeline (including forward purchase of Epiisod Macquarie Park) to scale the platform; leverage expected to remain moderate post-deployment (~31%).

h) Ownership & Lock-ins

Sponsor ~45.8% post-offer; cornerstone investors ~35.7%; offer free float ~15.2% (higher if over-allotment exercised). Sponsor and related parties: 6-month lock-up + next 6 months (50% of units). DBS own-book cornerstone: 6-month lock-up.

7) Snapshot Metrics (Mobile-Friendly Table)

Metric CA-REIT (at IPO)
Offer Price S$0.88
P/B (vs NAV/Unit ~S$0.837) ~1.05×
Forecast Distribution Yield 7.47% (FY2026) / 8.11% (FY2027)
Aggregate Leverage ~20.9% at IPO; ~31.0% post Epiisod
ICR ~4.6× (FY2026) / ~4.8× (FY2027)
Portfolio Beds ~26,870 (PBWA ~21,282; PBSA ~2,772)
Occupancy ~96.9% (PBWA) / ~96.8% (PBSA)
Over-allotment Option 51,137,000 units (19.5% of offer)

Peer and concurrent-IPO comparisons can be added on listing/pricing day when live market data is available.

8) Research & Opinions

At preliminary stage, formal sell-side initiations and price targets are typically released closer to listing or after trading commences. None publicly available at time of writing.

10) Investment Take & Day-1 Range

Verdict: Worth Considering for income investors seeking a high single-digit yield with conservative initial leverage and visible demand drivers.

  • Positives: 7.5–8.1% forecast yield, ~97% occupancy, low-20% gearing at IPO, robust cornerstone demand, and stabilisation support.
  • Watch-items: Construction-cycle exposure (PBWA), FX/interest-rate sensitivity, and potential supply from un-locked cornerstones post-listing.

Estimated debut range: S$0.89 – S$0.94 (flat to ~+7% vs S$0.88), bias to trade mildly above offer on steady orderbook and stabilisation.

11) Prospectus

Preliminary prospectus lodged on 11 Sep 2025. To access, click here 

Disclaimer: Information reflects the preliminary prospectus stage and may change upon registration, pricing, and listing. This is not investment advice.

Singapore Airlines (SIA SP): Strong Finish, HOLD Rating – Maybank Research Report 2025

Maybank Research Pte Ltd May 16, 2025 Singapore Airlines: A Strong Finish with Bumper Dividends, But HOLD for Now Executive Summary: Singapore Airlines FY4Q25 Performance Singapore Airlines (SIA SP) reported a strong FY4Q25, marked...

Raffles Medical Group (RFMD) 1H25 Results: Buy Rating Maintained, China Turnaround Expected in 2026 | Target Price S$1.25

UOB Kay Hian Date of Report: 29 July 2025 Raffles Medical Group: Margins Resilient, China Turnaround in Sight as 1H25 Results Slightly Miss Expectations Overview: Raffles Medical Group Financial Snapshot and Market Position Raffles...

Genting Singapore (GENS) 2Q25 Earnings Preview: Profitability Set to Climb as New Attractions Open at Resorts World Sentosa

CGS International July 24, 2025 Genting Singapore Poised for Profitability Surge in 2Q25: Key Insights, Peers Comparison, and Financial Outlook Introduction: Positive Momentum for Genting Singapore in 2Q25 Genting Singapore (GENS), a leading player...